Deciphering mechanisms of Listeria placental-fetal invasion
破译李斯特菌胎盘-胎儿侵袭机制
基本信息
- 批准号:10436619
- 负责人:
- 金额:$ 39.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-14 至 2022-06-14
- 项目状态:已结题
- 来源:
- 关键词:Amino AcidsAntibiotic TherapyBacteriaBacterial InfectionsBindingBirthBrain AbscessCardiacCardiac MyocytesCell surfaceCellsCellular Metabolic ProcessCessation of lifeDataDiseaseEmbryonic DevelopmentExhibitsFetal DeathFetal DevelopmentFetal TissuesFetusFoodFood ProcessingFrequenciesFunctional disorderGenetic CrossesGentamicinsGoalsGrowth Factor ReceptorsHealthHeartHumanImmune responseImmune signalingImmunocompromised HostIn VitroInfectionInjuryInlB proteinListeriaListeria monocytogenesMembrane ProteinsMeningitisMeningoencephalitisModificationMolecularMothersMusNeonatalOrganismPathogenicityPathologyPharmaceutical PreparationsPlacentaPlacentationPlayPregnancyPregnancy OutcomePregnant WomenProteinsRecording of previous eventsResistanceRoleSignal PathwaySpontaneous abortionSurfaceTeratogenic effectsTertiary Protein StructureTissuesVariantVertical Disease TransmissionVirulenceWomanWorkZika Virusbasecell typefetalfetal immunityfetal infectionfoodbornefoodborne outbreakhigh risk populationin vivoindividual patientinfant infectioninsightmicroorganismmortalitynovel therapeutic interventionolder patientpathogenpathogenic bacteriapregnantreceptorreceptor bindingstillbirthtissue tropismtransmission processuptakeviral resistancewasting
项目摘要
Project Summary
Listeria monocytogenes (Lm) is a gram-positive food-borne intracellular bacterial pathogen that is
capable of causing serious invasive disease in humans. As a widespread environmental organism,
Lm is a frequent contaminant of food processing facilities and has been responsible for some of the
largest, most expensive, and most deadly food recalls in US history. Lm is one of a select number of
pathogens that is transmitted during pregnancy from mother to fetus. These infections can be
devastating, as often an infected woman does not even realize she has been infected with Lm until
she miscarries or gives birth to a stillborn or systemically infected infant. The high mortality rate and
devastating sequelae that accompany Lm invasive disease despite antibiotic treatment underlie the
critical need for new therapeutic strategies to safely and effectively manage Lm invasive infections.
We have recently discovered that select isolates of Lm have an enhanced ability to target the placenta
and fetus based on increased expression of the bacterial surface protein InlB. Increased InlB is
sufficient to transform a strain that normally exhibits a low frequency of fetal colonization to a strain
that is capable off nearly 100% fetal infection. Naturally occurring amino acid variations within InlB
may both increase protein stability and enhance stimulation of c-Met, the host growth factor receptor
bound by InlB. Met is abundantly expressed by placental tissue and is required for embryonic and
placental development. We hypothesize that Lm strains expressing select variants of InlB exhibit
enhanced invasion through the manipulation of c-Met signaling pathways, leading to increased rates
of fetal transmission. These strains additionally stimulate a robust immune response that leads to
placental barrier dysfunction and fetal death. The specific aims of this proposal will undertake a
functional assessment of Lm InlB to reveal molecular mechanisms underlying vertical transmission as
well as examine the contributions of maternal and fetal immune signaling to pregnancy outcome. Aim
1 will functionally define the mechanisms underlying InlB surface localization and activity. This aim will
define mechanisms that contribute to InlB stability at the bacterial cell surface and will examine
functional differences between surface localization and secretion. Aim 2 will decipher the mechanisms
underlying InlB enhancement of Lm vertical transmission. We will examine and compare portals of Lm
entry in pregnant mice, and explore host responses to Lm infection that influence pregnancy outcome.
Aim 3 will explore maternal and fetal defenses triggered by high efficiency vertically transmitted
strains that contribute to pathology. These studies will clarify how select Lm isolates gain access with
high efficiency to placental/fetal tissues to cause devastating forms of neonatal disease and death.
项目概要
单核细胞增生李斯特菌 (Lm) 是一种革兰氏阳性食源性细胞内细菌病原体,
能够引起人类严重的侵袭性疾病。作为一种广泛存在的环境生物,
Lm 是食品加工设施中常见的污染物,是导致某些问题的原因之一。
美国历史上最大规模、最昂贵、最致命的食品召回事件。 Lm 是选定数量之一
怀孕期间从母亲传播给胎儿的病原体。这些感染可能是
毁灭性的,因为受感染的妇女常常甚至没有意识到自己已经感染了 Lm,直到
她流产或生下死产或全身感染的婴儿。高死亡率和
尽管抗生素治疗,但伴随 Lm 侵袭性疾病的毁灭性后遗症是
迫切需要新的治疗策略来安全有效地管理 Lm 侵袭性感染。
我们最近发现 Lm 的精选分离株具有增强的靶向胎盘的能力
和胎儿基于细菌表面蛋白InlB表达的增加。 InlB 增加是
足以将通常表现出低胎儿定植频率的菌株转化为菌株
几乎可以100%消除胎儿感染。 InlB 中天然存在的氨基酸变异
可能会增加蛋白质稳定性并增强对宿主生长因子受体 c-Met 的刺激
受 InlB 约束。胎盘组织大量表达蛋氨酸,是胚胎和胚胎发育所必需的。
胎盘发育。我们假设表达 InlB 特定变体的 Lm 菌株表现出
通过操纵 c-Met 信号通路增强侵袭,从而导致发生率增加
胎儿传播。这些菌株还刺激强大的免疫反应,从而导致
胎盘屏障功能障碍和胎儿死亡。该提案的具体目标将采取
Lm InlB 的功能评估揭示垂直传播的分子机制
并检查母体和胎儿免疫信号对妊娠结局的贡献。目的
图1将在功能上定义InlB表面定位和活性的潜在机制。这一目标将
定义有助于细菌细胞表面 InlB 稳定性的机制,并将检查
表面定位和分泌之间的功能差异。目标 2 将破译其机制
Lm 垂直传输的潜在 InlB 增强。我们将检查和比较 Lm 的门户
进入怀孕小鼠,并探索宿主对影响妊娠结局的 Lm 感染的反应。
目标 3 将探索高效率垂直传播引发的母体和胎儿防御
有助于病理学的菌株。这些研究将阐明选择 Lm 分离株如何获得访问权
对胎盘/胎儿组织具有高效率,可导致毁灭性的新生儿疾病和死亡。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nancy Elizabeth Freitag其他文献
Nancy Elizabeth Freitag的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nancy Elizabeth Freitag', 18)}}的其他基金
Deciphering mechanisms of Listeria placental-fetal invasion
破译李斯特菌胎盘-胎儿侵袭机制
- 批准号:
10363099 - 财政年份:2022
- 资助金额:
$ 39.18万 - 项目类别:
Deciphering mechanisms of Listeria placental-fetal invasion
破译李斯特菌胎盘-胎儿侵袭机制
- 批准号:
10646152 - 财政年份:2022
- 资助金额:
$ 39.18万 - 项目类别:
Deciphering the impact of sedative choice on the dynamics of Klebsiella pneumoniae lung infection
解读镇静剂选择对肺炎克雷伯菌肺部感染动态的影响
- 批准号:
10350966 - 财政年份:2021
- 资助金额:
$ 39.18万 - 项目类别:
Deciphering the impact of sedative choice on the dynamics of Klebsiella pneumoniae lung infection
解读镇静剂选择对肺炎克雷伯菌肺部感染动态的影响
- 批准号:
10527379 - 财政年份:2021
- 资助金额:
$ 39.18万 - 项目类别:
Deciphering mechanisms of Listeria placental-fetal invasion
破译李斯特菌胎盘-胎儿侵袭机制
- 批准号:
9234679 - 财政年份:2017
- 资助金额:
$ 39.18万 - 项目类别:
Deciphering how bacterial pheromone signaling enhances Listeria virulence
破译细菌信息素信号如何增强李斯特菌毒力
- 批准号:
8806236 - 财政年份:2014
- 资助金额:
$ 39.18万 - 项目类别:
Deciphering how bacterial pheromone signaling enhances Listeria virulence
破译细菌信息素信号如何增强李斯特菌毒力
- 批准号:
8965502 - 财政年份:2014
- 资助金额:
$ 39.18万 - 项目类别:
21st Annual Midwest Microbial Pathogenesis Conference
第21届年度中西部微生物发病机制会议
- 批准号:
8785218 - 财政年份:2014
- 资助金额:
$ 39.18万 - 项目类别:
Deciphering how anesthetics increase host susceptibility to microbial infection
破译麻醉剂如何增加宿主对微生物感染的易感性
- 批准号:
8462202 - 财政年份:2012
- 资助金额:
$ 39.18万 - 项目类别:
Deciphering how anesthetics increase host susceptibility to microbial infection
破译麻醉剂如何增加宿主对微生物感染的易感性
- 批准号:
8383227 - 财政年份:2012
- 资助金额:
$ 39.18万 - 项目类别:
相似海外基金
SBIR Phase II: Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections
SBIR II 期:开发尿液试纸测试,可以指导复杂尿路感染的立即和适当的抗生素治疗
- 批准号:
2213034 - 财政年份:2023
- 资助金额:
$ 39.18万 - 项目类别:
Cooperative Agreement
Personalized Antibiotic Therapy in the Emergency Department: PANTHER Trial
急诊科的个性化抗生素治疗:PANTHER 试验
- 批准号:
10645528 - 财政年份:2023
- 资助金额:
$ 39.18万 - 项目类别:
Strategies for improving the efficacy of combinatorial antibiotic therapy in chronic infections
提高慢性感染联合抗生素治疗疗效的策略
- 批准号:
10736285 - 财政年份:2023
- 资助金额:
$ 39.18万 - 项目类别:
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures
一种治疗感染性骨折的新型骨靶向抗生素疗法
- 批准号:
10603486 - 财政年份:2023
- 资助金额:
$ 39.18万 - 项目类别:
Severe Cutaneous Adverse Reactions Following Outpatient Antibiotic Therapy: A Population-based Study
门诊抗生素治疗后的严重皮肤不良反应:一项基于人群的研究
- 批准号:
449379 - 财政年份:2020
- 资助金额:
$ 39.18万 - 项目类别:
Studentship Programs
Sex-Specific Differences in End-of-Life Burdensome Interventions and Antibiotic Therapy in Nursing Home Residents With Advanced Dementia
患有晚期痴呆症的疗养院居民的临终干预和抗生素治疗的性别差异
- 批准号:
422034 - 财政年份:2020
- 资助金额:
$ 39.18万 - 项目类别:
Optimizing outpatient parenteral antibiotic therapy to support hospital-in-the-home program across the unique environmental conditions of Australia
优化门诊肠外抗生素治疗,以支持澳大利亚独特环境条件下的家庭医院计划
- 批准号:
nhmrc : 1197866 - 财政年份:2020
- 资助金额:
$ 39.18万 - 项目类别:
Investigator Grants
Resistance evolution in the presence of combination antibiotic therapy
联合抗生素治疗下耐药性的演变
- 批准号:
2241853 - 财政年份:2019
- 资助金额:
$ 39.18万 - 项目类别:
Studentship
Host-pathogen interactions in antibiotic therapy for listeriosis
李斯特菌病抗生素治疗中宿主与病原体的相互作用
- 批准号:
18K07106 - 财政年份:2018
- 资助金额:
$ 39.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones
多用途靶向纳米抗生素疗法可对抗骨骼中的严重感染
- 批准号:
9788269 - 财政年份:2018
- 资助金额:
$ 39.18万 - 项目类别:














{{item.name}}会员




